Clinical trials
Study name: PROTAXEL PHASE I STUDY. Single - center open study of the toxicity, safety, tolerability and kinetics of individually ascending doses of Protaxel in patients with refractory/recurrent ovarian or prostate cancer.
Study type: Phase I clinical trial
Population: Paclitaxel refractory/recurrent advanced ovarian or prostate cancer patients
Protocol number: PTX-I-01 2001
Status: Terminated
Study name: PROTAXEL PHASE I STUDY. Single - center open study of the toxicity, safety, tolerability and kinetics of individually ascending doses of Protaxel in patients with refractory/recurrent ovarian or prostate cancer.
Study type: Phase I clinical trial
Population: Paclitaxel refractory/recurrent advanced ovarian or prostate cancer patients
Protocol number: PTX-I-01 2001
Status: Terminated
Study name: A ramdomized, single-dose, two-way crossover study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing itraconazole.
Study type: Bioequivalence study
Population: Healthy volunteers
Protocol number: 78/016/02-iqa
Status: Terminated
Study name: A ramdomized, single-dose, two-way crossover study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing itraconazole.
Study type: Bioequivalence study
Population: Healthy volunteers
Protocol number: 78/016/02-iqa
Status: Terminated
Study name: A ramdomized, single-dose, two-way crossover study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing azithromycine.
Study type: Bioequivalence study
Population: Healthy volunteers
Protocol number: 77/011/02-iqa
Status: Terminated
Study name: A ramdomized, single-dose, two-way crossover study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing azithromycine.
Study type: Bioequivalence study
Population: Healthy volunteers
Protocol number: 77/011/02-iqa
Status: Terminated
Study name: A ramdomized, single-dose, two-way crossover study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing glibenclamide (glyburide).
Study type: Bioequivalence study
Population: Healthy volunteers
Protocol number: 77/012/02-iqa
Status: Terminated
Study name: A ramdomized, single-dose, two-way crossover study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing glibenclamide (glyburide).
Study type: Bioequivalence study
Population: Healthy volunteers
Protocol number: 77/012/02-iqa
Status: Terminated
Study name: A ramdomized, single-dose, two-way crossover study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing pioglitazone.
Study type: Bioequivalence study
Population: Healthy volunteers
Protocol number: 78/015/02-iqa
Status: Terminated
Study name: A ramdomized, single-dose, two-way crossover study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing pioglitazone.
Study type: Bioequivalence study
Population: Healthy volunteers
Protocol number: 78/015/02-iqa
Status: Terminated